COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,432 Articles (22,835 medRxiv, 8,597 bioRxiv)

Most recent first Previous |  Page 1062: Articles 10611-10620  | Next

Conformational Flexibility and Local Frustration in the Functional States of the SARS-CoV-2 Spike B.1.1.7 and B.1.351 Variants: Mutation-Induced Allosteric Modulation Mechanism of Functional Dynamics and Protein Stability
Verkhivker, G.
10.1101/2021.12.22.473892 — Posted: 2021-12-23
Computational Mapping of the Human-SARS-CoV-2 Protein-RNA Interactome
Horlacher, M., Oleshko, S., Hu, Y., Ghanbari, M., Vergara, E. E., Mueller, N., Ohler, U., Moyon, L., Marsico, A.
10.1101/2021.12.22.472458 — Posted: 2021-12-23
Tutorial: Investigating SARS-CoV-2 evolution and phylogeny using MNHN-Tree-Tools
Haschka, T.
10.1101/2021.12.21.473702 — Posted: 2021-12-23
Rapid longitudinal SARS-CoV-2 intra-host emergence of novel haplotypes regardless of immune deficiencies
Manuto, L., Grazioli, M., Spitaleri, A., Fontana, P., Bianco, L., Bertolotti, L., Bado, M., Mazzotti, G., Bianca, F., Onelia, F., Lorenzin, G., Simeoni, F., Lazarevic, D., Franchin, E., Del Vecchio, C., Dorigatti, I., Tonon, G., Cirillo, d., Lavezzo, E., Crisanti, A., Toppo, S.
10.1101/2021.12.22.473949 — Posted: 2021-12-23
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses
Chatterjee, D., Tauzin, A., Marchitto, L., Gong, S. Y., Boutin, M., Bourassa, C., Beaudoin-Bussieres, G., Bo, Y., Ding, S., Laumaea, A., Vezina, D., Perreault, J., Gokool, L., Morrisseau, C., Arlotto, P., Fournier, E., Guilbault, A., Delisle, B., Levade, I., Goyette, G., Gendron-Lepage, G., Medjahed, H., De Serres, G., Tremblay, C., Martel-Laferriere, V., Kaufmann, D. E., Bazin, R., Prevost, J., Moreira, S., Richard, J., Cote, M., Finzi, A.
10.1101/2021.12.21.473679 — Posted: 2021-12-23
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
Lusvarghi, S., Pollett, S. D., Neerukonda, S. N., WANG, W., Wang, R., Vassell, R., Epsi, N. J., Fries, A. C., Agan, B. K., Lindholm, D. A., Lalani, T., Mody, R., Ewers, E. C., Lalani, T., Ganesan, A., Goguet, E., Hollis-Perry, M., Coggins, S. A., Simons, M. P., Katzelnick, L. C., Wang, G., Broder, C. C., Tribble, D. R., Bentley, L. M., Eakin, A. E., Erlandson, K. J., Laing, E. D., Burgess, T. H., Mitre, E., Weiss, C. D.
10.1101/2021.12.22.473880 — Posted: 2021-12-23
Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant
Ikemura, N., Taminishi, S., Inaba, T., Arimori, T., Motooka, D., Katoh, K., Kirita, Y., Kirita, Y., Li, S., Itoh, Y., Ozaki, Y., Nakamura, S., Matoba, S., Standley, D. M., Okamoto, T., Takagi, J., Hoshino, A.
10.1101/2021.12.22.473804 — Posted: 2021-12-23
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice
Zani, A., Kenney, A., Kawahara, J., Eddy, A. C., Wang, X.-L., KC, M., Lu, M., Hemann, E. A., Li, J., Peeples, M. E., Hall-Stoodley, L., Forero, A., Cai, C., Ma, J., Yount, J. S.
10.1101/2021.12.22.473914 — Posted: 2021-12-23
Broad and Long-lasting Immune Response against SARS-CoV-2 Omicron and Other Variants by PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine (YS-SC2-010)
Liu, Y., Zhang, N., Wang, B., Zhang, Y.
10.1101/2021.12.22.473615 — Posted: 2021-12-23
Waning immune responses against SARS-CoV-2 among vaccinees in Hong Kong
Peng, Q., Zhou, R., Wang, Y., Zhao, M., Liu, N., Li, S., Huang, H., Yang, D., Au, K.-K., Wang, H., Man, K., Yuen, K.-Y., Chen, Z.
10.1101/2021.12.22.473934 — Posted: 2021-12-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).